Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Aterian Inc (ATER) vs Emerson Electric Co. (EMR) Price & Performance

Aterian IncTrade
Emerson Electric Co.Trade

Price performance (Past 24H)

Key statistics

Aterian Inc vs Emerson Electric Co. — how do they compare? Aterian Inc trades at $0.46 (market cap $5.32M), while Emerson Electric Co. trades at $164.19 (market cap $91.69B). The key difference: Emerson Electric Co. is far larger — about 17235× Aterian Inc's market cap, and Emerson Electric Co. pays a 1.35% dividend while Aterian Inc pays none. Which is the better fit depends on your goals.

ATEREMR
Market Cap
$5.32M$91.69B
Sector
Consumer CyclicalIndustrials
52-Week High
$1.39$164.38
52-Week Low
$0.36$123.30
Enterprise Value
$5.90M$102.77B
Dividend Yield
1.35%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Aterian Inc

Aterian (ATER) trades at $0.489, up 1.88% with a bearish technical signal despite recent earnings beats. The company faces significant financial challenges with negative net income margins (-30.78%) and declining revenue from $221M in 2022 to $69M in 2025. Recent news highlights a pending asset sale that could return $0.85-$1.14 per share to stockholders, creating near-term catalyst potential. Cash flow remains negative at -$13.14M for 2025, though the balance sheet shows $18M cash against $19.3M current liabilities.

The outlook hinges on the proposed asset sale delivering shareholder value, with technical indicators suggesting caution. Investment opportunity exists if the sale completes favorably, but risks include ongoing operational losses, declining revenue, and negative cash flow. Analyst sentiment is split 50/50 buy/hold, reflecting uncertainty about the company's turnaround prospects beyond the immediate transaction.

Emerson Electric Co.

Emerson Electric (EMR) trades at $164.56, up 3.7% on the day, reflecting strong momentum after three consecutive quarterly earnings beats. The stock exhibits a bullish technical setup, with key resistance at $168, while fundamentals show solid revenue growth and a 13.83% net income margin. Recent news highlights Q3 2026 results exceeding expectations, driven by 7% organic growth and strategic acquisitions like Glue Inc. to bolster AI capabilities in test and measurement.

Outlook remains positive with raised 2026 guidance, though valuation multiples like a P/E of 35.97 suggest premium pricing. Risks include execution challenges in integrating acquisitions and macroeconomic pressures on industrial demand. Analyst consensus favors Buy ratings with a $171.33 price target, indicating modest upside potential from current levels.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Aterian Inc

Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products, and consumer electronics. It has various owned and operated brands include Vremi, Healing Solutions, Xtava, TRUWEO, Spiralize, Pohl+Schmitt, and RIF6. The company generates revenue through the online sales of various consumer products that are sold online.

Read more on ATER

About Emerson Electric Co.

Emerson Electric is a multi-industrial conglomerate that operates under two business platforms: automation solutions and commercial and residential solutions. The latter is further subdivided into two operating segments: climate technologies, which sells HVAC and refrigeration products and services as well as tools and home products, which sells tools and compressors, among other products and services. Commercial and residential solutions boasts several household brands, including Copeland and RIDGID. Automation solutions is most known for its process manufacturing solutions, which consists of measurement instrumentation, as well as valves and actuators, among other products and services. Roughly half of the firm's geographic sales take place in the United States.

Read more on EMR